Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats

Carcinogenesis
T TanakaHajime Ohigashi

Abstract

The modifying effects of citrus auraptene given during the initiation and post-initiation phases of oral carcinogenesis initiated with 4-nitroquinoline 1-oxide (4-NQO) were investigated in male F344 rats. At 6 weeks of age, animals were divided into experimental and control groups, and fed the diets containing 100 ppm or 500 ppm auraptene. At 7 weeks of age, all animals except those treated with auraptene alone and control groups were given 4-NQO (20 ppm) in the drinking water for 8 weeks to induce tongue carcinoma. Starting 7 days before the 4-NQO exposure, groups of animals were fed the diets containing auraptene (100 and 500 ppm) for 10 weeks and then switched to the basal diet. Starting 1 week after the cessation of 4-NQO exposure, the groups given 4-NQO and a basal diet were switched to the diets mixed with auraptene (100 and 500 ppm), and maintained on these diets for 22 weeks. The other groups consisted of rats fed auraptene alone (500 ppm) or untreated rats. All rats were necropsied at the termination of the study (week 32). The incidences of tongue lesions (neoplasms and preneoplasms), polyamine levels in the tongue tissue and cell proliferation activity estimated by 5-bromodeoxyuridine (BrdU)-labelling index were comp...Continue Reading

Citations

Jun 1, 2000·Asia Pacific Journal of Clinical Nutrition·S Balasenthil, S Nagini
Jun 30, 2012·BMC Complementary and Alternative Medicine·Annie MarquisDaniel Grenier
Mar 8, 2000·Bioscience, Biotechnology, and Biochemistry·A MurakamiH Ohigashi
Jan 16, 2013·International Journal of Breast Cancer·Prasad Krishnan, Heather Kleiner-Hancock
Jun 11, 2011·Pathology Research International·Takuji TanakaTakahiro Tanaka
Feb 25, 2011·Nitric Oxide : Biology and Chemistry·Kunishige OnumaFutoshi Okada
Oct 29, 2008·European Journal of Pharmacology·Tomohiro NabekuraShuji Kitagawa
Jul 21, 2011·Journal of Oncology·Takuji Tanaka, Rikako Ishigamori
Jan 6, 2006·International Journal of Cancer. Journal International Du Cancer·Hiroyuki KohnoTakuji Tanaka
Jun 19, 2012·Journal of Experimental & Clinical Cancer Research : CR·Vinita BatraHeather E Kleiner-Hancock
Feb 2, 2006·Oral Oncology·Deepak Kanojia, Milind M Vaidya
Jan 10, 2014·Toxicology Mechanisms and Methods·Gustavo Protasio Pacheco de JesusDaniel Araki Ribeiro
Oct 23, 2004·Drug Metabolism and Pharmacokinetics·Hiroyuki TsudaMalcolm A Moore
Jul 18, 2014·Archives of Oral Biology·B Baldasquin-CaceresV Vicente-Ortega
Jul 5, 2017·Phytotherapy Research : PTR·Mahdi MoussaviShokouhozaman Soleymanifard
May 22, 2016·Technology in Cancer Research & Treatment·Saffiyeh Saboor-MalekiMehrdad Iranshahi
Jun 18, 2009·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Mehrdad IranshahiHarukuni Tokuda
Aug 13, 2010·Molecular Pharmacology·Philippe de MedinaMarc Poirot
Aug 20, 2019·BioFactors·Bahram BibakAmirhossein Sahebkar
Oct 7, 2018·Clinical Oral Investigations·Nashwan Al-AfifiAnand Ramanathan
May 16, 2020·International Journal of Radiation Biology·Hamide SalariFatemeh B Rassouli
Feb 28, 2020·Journal of Oncology·May Al-KoshabManimalar Selvi Naicker
Jan 14, 2021·Scientific Reports·Tsuneyuki MiyazakiMasahito Shimizu
Jun 9, 2019·Archives of Oral Biology·Nashwan Abdullah Al-AfifiMarina Mohd Bakri
Dec 17, 2009·Journal of Agricultural and Food Chemistry·G K JayaprakashaBhimanagouda S Patil
Jul 10, 2021·Frontiers in Pharmacology·Zahra Tayarani-NajaranSamira Eghbali

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.